Evolent Health (EVH) Misses Q1 EPS by 2c

Evolent Health (NYSE: EVH) reported Q1 EPS of $0.06, $0.02 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $483.65 million versus the consensus estimate of $460.58 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• Piper Sandler Reiterates Overweight Rating on Patterson-UTI Energy (PTEN)
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'